Navigation Links
YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING
Date:5/28/2009

MISSISSAUGA, ON, May 28 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that a poster presentation will report results from a randomized trial of nimotuzumab (aka BIOMAb/TheraCIM/h-R3) in patients with head and neck cancer conducted by Biocon Limited (Bangalore, India), a licensee of CIMAB SA, YM's licensor, at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Orlando, Florida from May 29 to June 2, 2009.

The poster entitled "A phase IIb 4-arm open-label randomized study to assess the safety and efficacy of h-R3 monoclonal antibody against EGFR in combination with chemoradiation therapy or radiation therapy in patients with advanced (stage III or IVA) inoperable head and neck cancer (abstract # 6041)" will be presented in the Head and Neck Cancer general poster session on Monday, June 1 from 8:00AM until 12:00PM on Level 2 in West Hall C.

About YM BioSciences

YM BioSciences Inc. is a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development. The Company is currently developing two late-stage products: nimotuzumab, an EGFR-targeting Affinity-Optimized Antibody(TM), and AeroLEF(R), a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl. YM has proven regulatory and clinical trial expertise and a diversified business model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization.

Nimotuzumab is a humanized monoclonal antibody in development worldwide, targeting multiple tumor types primarily in combination with radiation and chemorad
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
6. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
11. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: N...ng letter to its shareholders, discussing the Comp...iopharmaceuticals Holdings, Inc. (CHBP), an integr...e,s Republic of China. The merger gives NeoStem a ...ical Co. Ltd., CHBP,s primary operating subsidiary...
(Date:11/19/2009)...IK surgeons and recognized refractive and cataract...made brought their fellow surgeons up-to-date on t...y, cataract surgery, and ophthalmology in general ...halmology (AAO) annual meeting in San Francisco, C...er, Dr. David Huang, MD, Dr. Randy Epstein, Dr. Wi...
(Date:11/18/2009)...tute of Standards and Technology (NIST) has demons... detecting and measuring elusive hazards such as c... in food or pesticides distributed in soil by wind...than conventional techniques for detecting traces ...cules, having distinct electrically positive and n...
(Date:11/18/2009)...e in data analysis combined with Bio-Rad,s Bio...curricula provide state-of-the-art solutions to bi.... 18 Vernier Software & Techno..., sensors, and software and Bio-Rad Laboratories, ... of life science research and clinical diagnostics...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Prototype NIST method detects and measures elusive hazards 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) to...dependent Director, James N. Wilson, providing sha... , Dear Fellow Amylin Shareholder: , , As Lead I...day to provide a summary of exciting business deve...e slate of highly qualified and experienced indivi...
...2 Transgenomic, Inc. (OTC Bulletin Board: TBIO). ...y 2009 issue of the journal Human Mutation, a team...es in detail the key advantages of using Transgeno...anning of PKD1 and PKD2 , two important genes u...minant polycystic kidney disease (ADPKD). The assa...
...if., April 2 /PRNewswire-FirstCall/ -- ThermoGen...f innovative products and services that process an...ces will be the subject of several scientific abst...ll Therapy (ISCT) 2009 Annual Meeting in San Diego...acy of the Company,s BioArchive(R) System, MarrowX...
Other Biology Technology:Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 2Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 3Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 4Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 5Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 6Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 7Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 8Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology 2Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology 3Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology 4ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference 2ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference 3ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference 4
(Date:11/22/2009)...18, 2009 -- A butterfly,s proboscis looks like a s... it works more like a paper towel, according to Ko... borrow the tricks of this piece of insect anatomy...side of cells. , Kornev will present his work ne... Physical Society,s (APS) Division of Fluid Dynami...
(Date:11/22/2009)...arch Centre, a partnership of the University of Br...oastal Health Research Institute, have uncovered n...cells die following a stroke, as well as a possibl...study were recently published online in Nature Me...continue to die even after blood flow has been res...
(Date:11/20/2009)...rk on many scientific and technological frontiers....ided support that totals nearly $4.3 million for t...under the American Recovery and Reinvestment Act o...rants for investigation of solar phenomena. Philip...l enhance the capabilities of NJIT,s Big Bear Sola...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2As Predicted 3A Chronic Virus Found Living in Tumors of the Prostate 14170 1As Predicted 3A Chronic Virus Found Living in Tumors of the Prostate 14170 2BioCryst Receives Peramivir Request for Proposal From the U S Government 57737 1BioCryst Receives Peramivir Request for Proposal From the U S Government 57737 2BioCryst Receives Peramivir Request for Proposal From the U S Government 57737 3BioCryst Receives Peramivir Request for Proposal From the U S Government 57737 4PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long Acting Growth Hormone 14168 1PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long Acting Growth Hormone 14168 2PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long Acting Growth Hormone 14168 3PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long Acting Growth Hormone 14168 4
...iff Universitys School of Earth and Ocean Sciences...lled to Africa to find new evidence of climate cha...nding the appearance of the Antarctic ice sheet. ...the most important climatic shifts in Earths histo...evidence of the oceans cooling at this time, but i...
...artment of Biological and Environmental Sciences o... California in San Diego have discovered a gene th...on dioxide uptake for photosynthesis and water eva...lopment of drought-tolerant crops. The article is ... Online Publication (AOP) on 27 February 2008. , ...
...avoid the plant equivalent of vapor lock and a fav...l drought resistance of junipers, some varieties o... regions of the western United States, a Duke Univ...is that junipers are the most drought-resistant gr...on, a professor of global environmental change and...
Other Biology News:Has the mystery of the Antarctic ice sheet been solved? 2Breakthrough in plant research 2Why juniper trees can live on less water 2Why juniper trees can live on less water 3
Goat Anti-PITPN Antibody, Unconjugated from Raybiotech, Inc.
Rat Anti-Mouse CD205 (DEC-205) Monoclonal Antibody, Unconjugated, Clone NLDC-145 from Cell Sciences
Rabbit Anti-Human MT3-MMP Membrane-Type Metalloproteinase-3, propeptide domain, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Mouse Anti-Human gp340 Monoclonal Antibody, Unconjugated, Clone HYB213-01 from MBL International
Biology Products: